Bayforest Capital Ltd Has $616,000 Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Bayforest Capital Ltd boosted its stake in Doximity, Inc. (NASDAQ:DOCS) by 162.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,614 shares of the company’s stock after buying an additional 6,565 shares during the quarter. Bayforest Capital Ltd’s holdings in Doximity were worth $616,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Doximity by 4.5% in the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company’s stock valued at $598,159,000 after buying an additional 485,102 shares in the last quarter. FMR LLC lifted its stake in Doximity by 37.6% in the fourth quarter. FMR LLC now owns 9,409,313 shares of the company’s stock valued at $502,363,000 after acquiring an additional 2,571,580 shares during the last quarter. Geode Capital Management LLC grew its position in Doximity by 3.3% in the fourth quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company’s stock worth $157,668,000 after acquiring an additional 95,458 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of Doximity by 9.8% during the 4th quarter. Renaissance Technologies LLC now owns 1,847,702 shares of the company’s stock worth $98,649,000 after purchasing an additional 164,200 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its stake in shares of Doximity by 8.5% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,579,708 shares of the company’s stock worth $84,341,000 after purchasing an additional 124,216 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Performance

NASDAQ:DOCS opened at $59.68 on Wednesday. The firm’s 50-day moving average is $57.95 and its 200-day moving average is $59.69. The company has a market cap of $11.21 billion, a price-to-earnings ratio of 59.68, a PEG ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The company’s revenue for the quarter was up 17.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.25 EPS. Equities analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on DOCS shares. Bank of America lifted their price objective on shares of Doximity from $55.00 to $62.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. BTIG Research raised Doximity from a “neutral” rating to a “buy” rating and set a $80.00 price target for the company in a research report on Monday, June 2nd. JPMorgan Chase & Co. lowered their price objective on Doximity from $63.00 to $60.00 and set a “neutral” rating on the stock in a report on Tuesday, May 27th. Truist Financial raised their price objective on Doximity from $52.00 to $61.00 and gave the company a “hold” rating in a research note on Thursday, July 17th. Finally, The Goldman Sachs Group set a $50.00 target price on Doximity and gave the stock a “neutral” rating in a research report on Wednesday, May 21st. Ten equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $64.89.

Insider Transactions at Doximity

In other Doximity news, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the sale, the chief financial officer owned 357,165 shares in the company, valued at $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction on Friday, July 11th. The shares were sold at an average price of $60.04, for a total transaction of $300,200.00. Following the completion of the sale, the director directly owned 16,618 shares in the company, valued at $997,744.72. This trade represents a 23.13% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 76,000 shares of company stock worth $4,400,970 over the last quarter. 31.30% of the stock is owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.